Bavarian Nordic CEO sees massive sales potential for Covid-19 vaccine after securing state aid

If the company manages to produce a Covid-19 vaccine, the sales potential will be huge, says CEO Paul Chaplin, who is happy about the recent aid agreement reached with the Danish government.
Bavarian Nordic CEO Paul Chaplin | Photo: PR/ Bavarian Nordic
Bavarian Nordic CEO Paul Chaplin | Photo: PR/ Bavarian Nordic
BY SIGNE FERSLEV PEDERSEN & LEONORA BECK, TRANSLATED BY CATHERINE BRETT

Bavarian Nordic CEO Paul Chaplin predicts huge growth potential for its Covid-19 vaccine, as a EUR 108m financial support agreement with the Danish government fell into place on Monday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading